Douglas Roblin to Competitive Medical Plans
This is a "connection" page, showing publications Douglas Roblin has written about Competitive Medical Plans.
Connection Strength
0.041
-
Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations. Pharmacoepidemiol Drug Saf. 2009 Mar; 18(3):226-34.
Score: 0.021
-
Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf. 2007 Dec; 16(12):1275-84.
Score: 0.020